Email
Print
PEGylated Protein Therapeutics Market - Forecast(2024 - 2030)
1. PEGylated Protein Therapeutics Market - Overview
1.1 Definitions and Scope
2. PEGylated Protein Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. PEGylated Protein Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. PEGylated Protein Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. PEGylated Protein Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. PEGylated Protein Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. PEGylated Protein Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. PEGylated Protein Therapeutics Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Colony Stimulating Factor
8.3.2 Interferon
8.3.3 Erythropoietin
8.3.4 Recombinant Factor Viii
8.3.5 Monoclonal Antibody
8.3.6 Enzyme
8.3.7 Other Pegylated Protein Therapeutic
9. PEGylated Protein Therapeutics Market - By Sale Channel (Market Size -$Million / $Billion)
9.1 Hospital Pharmacy
9.2 Online Provider
9.3 Retail Pharmacy
10. PEGylated Protein Therapeutics - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Cancer
10.3.2 Autoimmune Disease
10.3.3 Hepatitis
10.3.4 Multiple Sclerosis
10.3.5 Hemophilia
10.3.6 Gastrointestinal Disorder
10.3.7 Other Application
11. PEGylated Protein Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 PEGylated Protein Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 PEGylated Protein Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 PEGylated Protein Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 PEGylated Protein Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 PEGylated Protein Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. PEGylated Protein Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. PEGylated Protein Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. PEGylated Protein Therapeutics Market - Key Company List by Country Premium
15. PEGylated Protein Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Amgen Inc
15.3 Astrazeneca Plc
15.4 Biogen Inc
15.5 F Hoffmann-La Roche Ltd
15.6 Horizon Pharma Plc
15.7 Leadiant Bioscience S P A
15.8 Merck Co , Inc
15.9 Pfizer Inc
15.10 Shire Plc
15.11 Ucb S A
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. PEGylated Protein Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. PEGylated Protein Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. PEGylated Protein Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. PEGylated Protein Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. PEGylated Protein Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. PEGylated Protein Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. PEGylated Protein Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. PEGylated Protein Therapeutics Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Colony Stimulating Factor
8.3.2 Interferon
8.3.3 Erythropoietin
8.3.4 Recombinant Factor Viii
8.3.5 Monoclonal Antibody
8.3.6 Enzyme
8.3.7 Other Pegylated Protein Therapeutic
9. PEGylated Protein Therapeutics Market - By Sale Channel (Market Size -$Million / $Billion)
9.1 Hospital Pharmacy
9.2 Online Provider
9.3 Retail Pharmacy
10. PEGylated Protein Therapeutics - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Cancer
10.3.2 Autoimmune Disease
10.3.3 Hepatitis
10.3.4 Multiple Sclerosis
10.3.5 Hemophilia
10.3.6 Gastrointestinal Disorder
10.3.7 Other Application
11. PEGylated Protein Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 PEGylated Protein Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 PEGylated Protein Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 PEGylated Protein Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 PEGylated Protein Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 PEGylated Protein Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. PEGylated Protein Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. PEGylated Protein Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. PEGylated Protein Therapeutics Market - Key Company List by Country Premium
15. PEGylated Protein Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Amgen Inc
15.3 Astrazeneca Plc
15.4 Biogen Inc
15.5 F Hoffmann-La Roche Ltd
15.6 Horizon Pharma Plc
15.7 Leadiant Bioscience S P A
15.8 Merck Co , Inc
15.9 Pfizer Inc
15.10 Shire Plc
15.11 Ucb S A
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. PEGylated Protein Therapeutics Market - Appendix16.1 Abbreviations
16.2 Sources
17. PEGylated Protein Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)1.1 Colony Stimulating Factor Market 2023-2030 ($M) - Global Industry Research
1.2 Interferon Market 2023-2030 ($M) - Global Industry Research
1.3 Erythropoietin Market 2023-2030 ($M) - Global Industry Research
1.4 Recombinant Factor Viii Market 2023-2030 ($M) - Global Industry Research
1.5 Monoclonal Antibody Market 2023-2030 ($M) - Global Industry Research
1.6 Enzyme Market 2023-2030 ($M) - Global Industry Research
2.Global Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
2.1 Hospital Pharmacy Market 2023-2030 ($M) - Global Industry Research
2.2 Online Provider Market 2023-2030 ($M) - Global Industry Research
2.3 Retail Pharmacy Market 2023-2030 ($M) - Global Industry Research
3.Global Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 (Volume/Units)
3.1 Colony Stimulating Factor Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Interferon Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Erythropoietin Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Recombinant Factor Viii Market 2023-2030 (Volume/Units) - Global Industry Research
3.5 Monoclonal Antibody Market 2023-2030 (Volume/Units) - Global Industry Research
3.6 Enzyme Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 (Volume/Units)
4.1 Hospital Pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Online Provider Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Retail Pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)
5.1 Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
5.2 Interferon Market 2023-2030 ($M) - Regional Industry Research
5.3 Erythropoietin Market 2023-2030 ($M) - Regional Industry Research
5.4 Recombinant Factor Viii Market 2023-2030 ($M) - Regional Industry Research
5.5 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
5.6 Enzyme Market 2023-2030 ($M) - Regional Industry Research
6.North America Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
6.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
6.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
6.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
7.South America Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)
7.1 Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
7.2 Interferon Market 2023-2030 ($M) - Regional Industry Research
7.3 Erythropoietin Market 2023-2030 ($M) - Regional Industry Research
7.4 Recombinant Factor Viii Market 2023-2030 ($M) - Regional Industry Research
7.5 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
7.6 Enzyme Market 2023-2030 ($M) - Regional Industry Research
8.South America Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
8.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
8.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
8.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
9.Europe Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)
9.1 Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
9.2 Interferon Market 2023-2030 ($M) - Regional Industry Research
9.3 Erythropoietin Market 2023-2030 ($M) - Regional Industry Research
9.4 Recombinant Factor Viii Market 2023-2030 ($M) - Regional Industry Research
9.5 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
9.6 Enzyme Market 2023-2030 ($M) - Regional Industry Research
10.Europe Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
10.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
10.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
10.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
11.APAC Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)
11.1 Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
11.2 Interferon Market 2023-2030 ($M) - Regional Industry Research
11.3 Erythropoietin Market 2023-2030 ($M) - Regional Industry Research
11.4 Recombinant Factor Viii Market 2023-2030 ($M) - Regional Industry Research
11.5 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
11.6 Enzyme Market 2023-2030 ($M) - Regional Industry Research
12.APAC Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
12.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
12.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
12.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
13.MENA Pegylated Protein Therapeutic Market, By Product Type Market 2023-2030 ($M)
13.1 Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
13.2 Interferon Market 2023-2030 ($M) - Regional Industry Research
13.3 Erythropoietin Market 2023-2030 ($M) - Regional Industry Research
13.4 Recombinant Factor Viii Market 2023-2030 ($M) - Regional Industry Research
13.5 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
13.6 Enzyme Market 2023-2030 ($M) - Regional Industry Research
14.MENA Pegylated Protein Therapeutic Market, By Sale Channel Market 2023-2030 ($M)
14.1 Hospital Pharmacy Market 2023-2030 ($M) - Regional Industry Research
14.2 Online Provider Market 2023-2030 ($M) - Regional Industry Research
14.3 Retail Pharmacy Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)2.Canada PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
10.UK PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
12.France PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
16.China PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
17.India PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa PEGylated Protein Therapeutics Market Revenue, 2023-2030 ($M)
21.North America PEGylated Protein Therapeutics By Application
22.South America PEGylated Protein Therapeutics By Application
23.Europe PEGylated Protein Therapeutics By Application
24.APAC PEGylated Protein Therapeutics By Application
25.MENA PEGylated Protein Therapeutics By Application
26.Amgen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Biogen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.F Hoffmann-La Roche Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Horizon Pharma Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Leadiant Bioscience S P A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Shire Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Ucb S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)